Target’s revenue declined 3.0% in the first quarter, underpinned by a 3.8% drop in comparable sales. Transaction count and ...

Marvell Technology Inc. delivered fiscal first-quarter results in line with expectations - but the latest numbers may be less important than the company's upcoming commentary, as some analysts on Wall ...

After raising our near-term assumptions, we are increasing our fair value estimate.

Boeing CEO Kelly Ortberg has positive news about the production rates, 737 MAX variants, and China. Investors look pleased. Microchip is performing better than management expected when it hosted its ...

The central bank lowered its benchmark interest-rate target to 8.5% from 9% on May 15. In the week through May 24, 240,000 people newly filed for unemployment benefits, compared with 226,000 the week ...

Trump selected Powell to be Fed chair in 2017, during his first term in the White House. Relations between the two quickly soured when the Fed hiked interest rates steadily after Trump's tax cut was ...

The regulator filed a joint motion with the company Thursday to drop the case. The SEC had charged Binance and Zhao in 2023 with several securities violations, alleging the company operated ...

Nvidia said the ramp-up of its Blackwell graphics processing units has been the fastest in company history, and that it is seeing increasing demand as hyperscalers focus on AI inference for reasoning ...

Cadence Design Systems has received a letter from the Commerce Department's Bureau of Industry and Security informing the company of new restrictions on exports to China.

In the week through May 24, 240,000 people newly filed for unemployment benefits, compared with 226,000 the week prior. Economists polled by The Wall Street Journal had been forecasting 230,000 ...

The Cambridge, Mass.-based biotechnology company's drug, BEAM-302, is a liver-targeting lipid nanoparticle formulation that is designed to correct for a mutation in patients with alpha-1 antitrypsin ...

Danaher and AstraZeneca have formed a partnership to develop diagnostic tools that help clinicians better determine which patients would benefit from precision medicine treatments.